pharma

Showing 15 posts of 2914 posts found.

Pharma’s global economic footprint is huge – and growing

March 26, 2015
Research and Development, Sales and Marketing Argentina, Asia, IFPMA, Oceania, global, gva, pharma

The pharma industry contributes more than $400 billion to the global economy, according to new research that examines the worldwide …

ABPI image

Pharma pays £310 million underwriting UK meds bill

March 13, 2015
Sales and Marketing ABPI, NHS, PPRS, body, department, health pricing, pharma

Pharma has made a fourth quarter payment of £81 million to underwrite the 2014 UK medicines bill under the Pharmaceutical …

Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

NICE is ‘setting prices too high’ for NHS

February 19, 2015
Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma

The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …

Alzheimer’s Research UK image

£30m drug discovery centres launched to overcome pharma ‘funding fatigue’

February 18, 2015
Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma

Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …

Biogen image

Pharma is boosting pipelines to avoid patent cliff

February 11, 2015
Sales and Marketing Biogen IDEC, Moody's, dimethyl fumarate, lilly, pharma, pipelines, sofosbuvir, sovaldi, tecfidera

Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …

Pharma image

Pharma’s reputation ‘is worsening among patients’

February 10, 2015
Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency

Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …

FDA image

Pharma adverse event FDA reports are inadequate

February 5, 2015
Sales and Marketing FDA, Gilead, Solvaldi, US Institute for Safe Medication Practices, pharma, sofosbuvir

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a …

Stephen Whitehead image

Stephen Whitehead: pharma has transformed

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

GSK image

GSK denies China job cutting rumours

January 27, 2015
Medical Communications, Research and Development, Sales and Marketing China, GSK, Jobs, Novartis, caixin, pharma

GlaxoSmithKline has told Pharmafile that the news and rumours circulating about 1,000 employees facing the axe in China are not …

Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

Pharma industry set for bumper 2015

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2015, FDA, bumper, harvoni, opdivo, pharma, sovaldi

Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …

AZ image

Pharma to lose $69 billion in five years as patents expire

December 12, 2014
Sales and Marketing AstraZeneca, GlobalData, Japanese firm Otsuka, Otsuka, lilly, pharma

Pharma companies are set to lose around $65 billion by 2019 due to drug patent expiries according to research firm …

Janssen image

Patient access schemes ‘lack transparency’

December 12, 2014
Research and Development, Sales and Marketing Janssen, NHS, NICE, Velcade, patient access, pharma, scheme

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …

Charity image

Charities must be clear about pharma funding

October 1, 2014
Medical Communications, Sales and Marketing ABPI, NICE, Sativex, charity, funding, mind, pharma

There is growing need for transparency around patient groups and health charities as they are widely perceived to be independent …

The Gateway to Local Adoption Series

Latest content